Nomograms for Predicting Disease-Free Survival Based on Core Needle Biopsy and Surgical Specimens in Female Breast Cancer Patients with Non-Pathological Complete Response to Neoadjuvant Chemotherapy.
Ailin LanHan LiJunru ChenMeiying ShenYudi JinYuran DaiLinshan JiangXin DaiYang PengShengchun LiuPublished in: Journal of personalized medicine (2023)
Two robust and effective nomo-grams were developed to personalize the prediction of DFS in non-pCR BC patients treated with NAC.